Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Frontage Laboratories Acquires Concord Biosciences | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Frontage Laboratories Acquires Concord Biosciences

The combining of the CROs will allow for quickly met regulatory requirements and internal development goals

By: Betsy Louda

, Contract Pharma

Frontage Laboratories has acquired Concord Biosciences, formerly known as Ricerca Biosciences, a preclinical contract research organization (CRO). 

 

Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with drug safety, metabolism, bioanalytical, residue and environmental fate studies.

 

“We have committed to build a global CRO company with integrated services,” said Dr. Song Li, founder and chief executive officer, Frontage Laboratories. “The acquisition of Concord Biosciences is a significant step toward reaching our goal. The addition of Concord Bio to the Frontage family will enable us to provide pharmaceutical product development services from lead selection to IND-enabling studies to commercialization. Additionally, the agrochemical expertise of Concord Bio will position Frontage as a major CRO in the agricultural products industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters